Brazilian health regulator Anvisa has refused to import the Russian vaccine Sputnik V Covid-19, which was requested by state governors, to fight the second deadly wave of the virus, which affects the largest country in Latin America.
Anvisa’s five-member board voted unanimously to refuse to approve the Russian vaccine after technicians identified “non-negative risks” and “serious” defects, citing a lack of information to ensure its safety, quality and effectiveness. , according to Reuters.
Ana Carolina Moreira Marino Araujo, general manager of health monitoring, said that given all the documentation provided, data obtained from personal inspections, and information from other regulators, the “inherent risks” were too great.